What Drugs Lower High Cortisol Levels?
Cortisol is a corticosteroid hormone made in the adrenal glands, two small organs sitting on top of each kidney. It is produced when the adrenals are stimulated by a hormone produced in the pituitary gland of the brain called adrenocorticotropic hormone (ACTH).
Cortisol has many important functions throughout the body, ranging from anti-inflammatory effects to maintaining blood pressure and blood sugar. Cortisol levels that are too high produce a number of abnormalities known collectively as Cushing syndrome 3. Adrenal and pituitary tumors are common causes of high cortisol.
Drug treatment generally includes steroidogenesis inhibitors, neuromodulatory medications or cortisol receptor antagonists. The choice often depends on the cause of the elevated cortisol, as well as possible side effects. If a single medication is not adequate, combinations are often used.
Steroidogenesis Inhibitors
Mitotane commonly causes digestive symptoms. It may also cause:
- decreased memory
- other neurologic symptoms
- liver dysfunction
- high cholesterol
- breast growth in men
- menstrual abnormalities or ovarian cysts in women
Aminoglutethimide may cause
- digestive symptoms
- drowsiness
- weakness
- a rash
- low blood pressure
- low thyroid hormone levels
Metyrapone can cause nausea, facial and body hair growth in women, as well as high blood pressure and low potassium levels.
Neuromodulatory Drugs
Hydrochlorot Side Effects
Learn More
Neuromodulatory drugs act primarily to decrease the release of ACTH from the pituitary. Bromocriptine (Parlodel), octreotide (Sandostatin), cyproheptadine (Periactin), pasireotide (Signfor) and cabergoline are examples of neuromodulatory drugs that may be used to treat high cortisol levels. The first three are of limited benefit in most patients. Pasireotide and cabergoline, however, are more effective. The most common side effects of pasireotide include digestive symptoms, headaches and elevated blood sugar levels. Cabergoline may cause nausea, low blood pressure, dizziness and psychological changes such as pathologic gambling. Rarely, heart valve problems may occur.
- Neuromodulatory drugs act primarily to decrease the release of ACTH from the pituitary.
- Bromocriptine (Parlodel), octreotide (Sandostatin), cyproheptadine (Periactin), pasireotide (Signfor) and cabergoline are examples of neuromodulatory drugs that may be used to treat high cortisol levels.
Cortisol Receptor Antagonists
Cortisol receptor antagonists are medications that block the actions of cortisol throughout the body. They do not directly lower cortisol levels. Mifepristone (Korlym, Mifeprex), a drug initially developed as an abortion pill, is the main cortisol receptor antagonist used to treat high cortisol levels 9. It is generally effective in counteracting the effects of excessive cortisol. But sometimes it can be too effective and cause symptoms of low cortisol, such as weakness and low blood sugar. Other possible side effects include heavy menstrual periods in women, low potassium levels and high blood pressure.
- Cortisol receptor antagonists are medications that block the actions of cortisol throughout the body.
- But sometimes it can be too effective and cause symptoms of low cortisol, such as weakness and low blood sugar.
Warnings and Precautions
Long-Term Effects of Amlodipine
Learn More
Most medications for high cortisol levels interact with a number of other drugs, so tell your doctor about all other medications you are taking. Aminoglutethimide, mifepristone, and mitotane should be not used if you are pregnant or might become pregnant. Pasireotide and mifepristone are the only medications that are actually approved by the Food and Drug Administration (FDA) to treat high cortisol levels. The other medications are approved by the FDA, but for other conditions.
Reviewed and revised by Mary D. Daley, MD.
- Most medications for high cortisol levels interact with a number of other drugs, so tell your doctor about all other medications you are taking.
- Pasireotide and mifepristone are the only medications that are actually approved by the Food and Drug Administration (FDA) to treat high cortisol levels.
Related Articles
References
- American Family Physician: Cushing's Disease -- Clinical Manifestations and Diagnostic Evaluation
- Johns Hopkins Medicine: Cushing’s Syndrome/Disease
- The Lancet: Cushing’s Syndrome
- Pituitary: Updates on the Role of Adrenal Steroidogenesis Inhibitors in Cushing’s Syndrome -- A Focus on Novel Therapies
- Endocrine and Metabolism Clinics: Medical Treatment of Cushing Disease -- New Targets, New Hope
- National Institutes of Health: What Are the Treatments for Cushing Syndrome?
- The Journal of Physiology: Cushing's Syndrome: From Physiological Principles to Diagnosis and Clinical Care
- DailyMed: Korlym -- Mifepristone Tablet
- DailyMed: Lysodren -- Mitotane Tablet
- DailyMed: Cabergoline -- Cabergoline Tablet
- Cushing’s disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment
- STRESS RELIEF: The Role of Exercise in Stress Management : ACSM's Health & Fitness Journal
- Association between Higher Serum Cortisol Levels and Decreased Insulin Secretion in a General Population
- Chronic Stress, Cortisol Dysfunction, and Pain: A Psychoneuroendocrine Rationale for Stress Management in Pain Rehabilitation
- Current Directions in Stress and Human Immune Function
- Effects of Cortisol on Carbohydrate, Lipid, and Protein Metabolism: Studies of Acute Cortisol Withdrawal in Adrenocortical Failure | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic
- Diurnal Cortisol Slopes and Mental and Physical Health Outcomes:A Systematic Review and Meta-analysis
- Cushing’s disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment
- Recent Updates on the Diagnosis and Management of Cushing's Syndrome
- Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior - PubMed
- Central adiposity and cortisol responses to waking in middle-aged men and women - PubMed
- Stress, cortisol, and other appetite-related hormones: Prospective prediction of 6-month changes in food cravings and weight
- Adrenal Insufficiency- etiology, diagnosis and treatment
- Adrenal insufficiency – recognition and management
- Addison’s disease: identification and management in primary care
- Regular exercise is associated with emotional resilience to acute stress in healthy adults
- The protective role of exercise on stress system dysregulation and comorbidities - PubMed
- STRESS RELIEF: The Role of Exercise in Stress Management : ACSM's Health & Fitness Journal
- Physical activity as a moderator of the association between emotional eating and BMI: evidence from the Swiss Food Panel - PubMed
- Effects of Exercise and Physical Activity on Anxiety
- Role of Physical Activity for Weight Loss and Weight Maintenance
- The Role of Exercise and Physical Activity in Weight Loss and Maintenance
- Mindful Eating: The Art of Presence While You Eat
- Mindful Eating: The Art of Presence While You Eat
- Pilot study: Mindful Eating and Living (MEAL): weight, eating behavior, and psychological outcomes associated with a mindfulness-based intervention for people with obesity - PubMed
- Intuitive eating is inversely associated with body weight status in the general population-based NutriNet-Santé study - PubMed
- Emotional eating and weight regulation: a qualitative study of compensatory behaviors and concerns
- Interactions between sleep, stress, and metabolism: From physiological to pathological conditions
- Sleep and obesity
- Association between Reduced Sleep and Weight Gain in Women | American Journal of Epidemiology | Oxford Academic
- The Association Between Sleep Duration and Weight Gain in Adults: A 6-Year Prospective Study from the Quebec Family Study
- Sleeping hours: what is the ideal number and how does age impact this?
- Effects of mindfulness meditation on serum cortisol of medical students - PubMed
- Influence of mindfulness practice on cortisol and sleep in long-term and short-term meditators - PubMed
- The effect of mindfulness meditation on sleep quality: a systematic review and meta-analysis of randomized controlled trials - PubMed
Writer Bio
Adam Scarano began writing as a freelancer in 2010 focusing on the fields of graphic design and media. He graduated from the Metropolitan State College of Denver with a Bachelor of Arts in English with a minor in digital media.